Musculoskeletal Pain
📧 Sign up to get email alerts when something new happens for Musculoskeletal Pain.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-06-17Clinical Trial Update: Effectiveness of Ergonomics Training and Exercise in Esports Players [NA]
The clinical trial examined the effectiveness of ergonomics training and exercise for esports players with musculoskeletal disorders and mus…
-
CLINICAL_TRIALS research · 2024-05-29Clinical Trial Update: Active Surveillance Reporting to Identify Adverse Events Following Chiropractic Care in Older Adults
This clinical trial update outlines an active surveillance study to identify adverse events following chiropractic care in older adults, wit…
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: vEAET for Older Veterans With Chronic Musculoskeletal Pain Pilot [NA]
The pilot trial evaluating vEAET for chronic musculoskeletal pain in older veterans has completed.
-
FDA approval · 2024-04-25FDA Approved: CYCLOBENZAPRINE HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for cyclobenzaprine hydrochloride submitted by Amneal Pharmaceuticals of New York LLC.
-
CLINICAL_TRIALS trial_result · 2024-04-04Clinical Trial Update: BFA Treatment of Pain [NA]
A completed clinical trial update for BFA focusing on musculoskeletal and acute pain with results posted in 2024.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-03-25Clinical Trial Update: Efficacy of Lidocaine Patch in Acute Musculoskeletal Pain in the Emergency Department [Phase 3]
A Phase 3 trial evaluating the efficacy of a lidocaine patch for acute musculoskeletal pain in emergency department settings has completed w…
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: Virtual Human Technology for Patients With Chronic Pain [NA]
A completed clinical trial evaluating virtual human technology for patients with chronic musculoskeletal pain; results posted.
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Acetaminophen (APAP) +/- Oxycodone [Phase 4]
Phase 4 clinical trial update for acetaminophen with or without oxycodone in musculoskeletal pain has completed; results posted in 2024.
-
CLINICAL_TRIALS withdrawal · 2024-02-28Clinical Trial Update: Topical CBD for Musculoskeletal Pain [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial of topical CBD for musculoskeletal pain was withdrawn.
-
FDA approval · 2023-12-19FDA Approved: DULOXETINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for duloxetine hydrochloride from Aurobindo Pharma Limited, granting regulatory clearance for a gene…
-
CLINICAL_TRIALS trial_result · 2023-11-21Clinical Trial Update: Reducing the Transition From Acute to Chronic Musculoskeletal Pain Among Older Adults [NA]
A completed clinical trial from UNC Chapel Hill studying strategies to reduce transition from acute musculoskeletal pain to chronic pain in …
-
CLINICAL_TRIALS trial_result · 2023-09-18Clinical Trial Update: Bonipar for Acute and Chronic Musculoskeletal Pain [Phase 2]
Phase 2 trial update for Bonipar in acute and chronic musculoskeletal pain has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: The Effect of the Erchonia GVL Low Level Laser Therapy on Neck and Shoulder Pain [NA]
Clinical trial update on Erchonia GVL low-level laser therapy for neck and shoulder musculoskeletal pain; study completed with results poste…
-
FDA approval · 2023-08-18FDA Approved: DRIZALMA SPRINKLE — Supplemental Application (SUN PHARMACEUTICAL INDUSTRIES, INC.)
The FDA approved Sun Pharmaceutical's supplemental NDA for Drizalma Sprinkle (duloxetine), adding a sprinkle-form formulation and related la…
-
FDA approval · 2023-08-17FDA Approved: CHLORZOXAZONE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Chlorzoxazone submitted by Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2023-08-15Clinical Trial Update: A Randomized Trial of NSAID Dosing Strategies [Phase 4]
A Phase 4 randomized trial evaluating dosing strategies for NSAIDs in musculoskeletal and acute pain conditions has completed.
-
FDA approval · 2023-08-09FDA Approved: CHLORZOXAZONE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved Rising Pharma's original ANDA for chlorzoxazone (generic) as a muscle relaxant to relieve muscle spasm associated with acute mu…
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: At-Home Telehealth Yoga for Treating Chronic Pain in People With Alzheimer's Disease and Their Caregiver's [NA]
A completed clinical trial evaluating at-home telehealth yoga for chronic pain in people with Alzheimer disease and their caregivers; result…
-
FDA approval · 2023-05-02FDA Approved: DULOXETINE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application from Actavis Pharma, Inc. for duloxetine under ANDA 090776, granting approval for a supplemental cha…
-
FDA approval · 2023-05-02FDA Approved: DULOXETINE — Supplemental Application (Solco Healthcare US, LLC)
The FDA approved a supplemental application for duloxetine submitted by Solco Healthcare US, LLC (ANDA206653), authorizing a change related …
-
FDA approval · 2023-04-10FDA Approved: CHLORZOXAZONE — Original Application (Lifsa Drugs LLC)
The FDA approved Lifsa Drugs LLC's chlorzoxazone under ANDA214702 as an original application for a generic product.
-
CLINICAL_TRIALS trial_result · 2023-04-04Clinical Trial Update: GET Living: Graded Exposure Treatment for Children and Adolescents With Chronic Pain [NA]
Completed clinical trial evaluating graded exposure treatment for children and adolescents with chronic pain, with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-03-23Clinical Trial Update: Feasibility of At-Home Telehealth Yoga for Treating Chronic Pain [NA]
A completed clinical trial evaluating the feasibility of at-home telehealth yoga for treating chronic pain shows study results posted.
-
FDA approval · 2023-02-09FDA Approved: METHOCARBAMOL — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for methocarbamol from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2022-11-04Clinical Trial Update: A Personalized Behavioral Intervention for Older Adults With Musculoskeletal Pain and Sleep Complaints [NA]
A completed clinical trial evaluating a personalized behavioral intervention for older adults with musculoskeletal pain and sleep complaints…